Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17Head & Neck 4Gynecologic 3Genitourinary 3Tumor-Agnostic 2Thoracic 2Other 2Endocrine 2Sarcoma 1NET 1Breast 1

Conditions

Neoplasms 2

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Robotic Surgical Procedures × Tumor-Agnostic × Clear all
NCT04647188 2023-09-26

MASTERY

University of Birmingham

Unknown
500 enrolled
Tumor-Agnostic

Neoplasms

NCT02274493 2019-03-26

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

M.D. Anderson Cancer Center

Phase NA Completed
15 enrolled 11 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡